Profil
Kristin Bedard served as the Chief Scientific Officer-Immuno oncology at Kineta, Inc. from 2016 to 2020.
She then worked as the Vice President-Immunobiology at Sutro Biopharma, Inc. from 2020 to 2023.
Dr. Bedard completed her undergraduate degree at The Pennsylvania State University in 1998.
She later earned her doctorate degree from the University of California, Irvine in 2005.
Ehemalige bekannte Positionen von Kristin Bedard
| Unternehmen | Position | Ende |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01.06.2023 |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01.02.2020 |
Ausbildung von Kristin Bedard
| The Pennsylvania State University | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
